1. Introduction {#sec1}
===============

Epidemiological research provides strong evidence for a link between repetitive work and the development of chronic muscle pain \[[@B1]--[@B3]\], but to fully understand this relationship, the pathophysiological mechanisms behind it needs further elucidating. Several hypotheses that focus on hypoxia or other metabolic effects in the muscle have been suggested \[[@B4]--[@B6]\].

While the muscle biopsy technique have only been able to provide a "snap-shot" of the muscle chemistry \[[@B7], [@B8]\], the possibilities for real-time in vivo investigations have been greatly improved by combining microdialysis and near-infrared spectroscopy \[[@B9], [@B10]\].

Microdialysis (MD) permits in vivo measurements of changes in substance concentrations in different tissues in response to work, with minimal trauma \[[@B11]\]. MD is performed by implanting a probe with a semipermeable membrane in the tissue and slowly perfuses it with a physiological solution. Sample collection is based on passive diffusion of substances over the membrane, preferable during steady-state conditions.

We have previously reported significantly increased \[lactate\] and \[glutamate\] and unchanged \[prostaglandin E2, PGE~2~\] in the trapezius muscle of healthy females, in response to low-load repetitive work (RW) which we interpreted as normal responses to increased physical demands \[[@B9]\]. We have also reported similar absolute \[glutamate\] and \[PGE~2~\] in females with trapezius myalgia (TM) and asymptomatic controls during rest \[[@B12]\]. Few other studies have used MD to further elucidate the pathophysiology behind work-related trapezius myalgia, and to some extent the findings are conflicting. In a laboratory study Rosendal et al. \[[@B13]\] reported increased intramuscular \[lactate\] and \[glutamate\] in response to RW in TM, but not in healthy controls, findings which they were unable to verify in an occupational field study \[[@B14]\]. However, the pain subjects differed in severity of symptoms between studies. Ashina et al. \[[@B15]\] reported similar \[glutamate\] and \[PGE2\] in trapezius muscle tender points in response to low-load static work in subjects with chronic tension type headache (CTTH).

Near-infrared spectroscopy (NIRS) is a noninvasive method for measuring muscle oxygenation (% StO~2~), that is, the dynamic balance between oxygen delivery to and consumption within a tissue \[[@B16], [@B17]\]. The technique is based on the principle of differential absorption properties of oxygenated and deoxygenated forms of haemoglobin (and to a lesser extent, myoglobin) in the near infrared range (760--850 nm). NIRS is well suited to study the muscle microcirculation due to the minimal absorption of light in small vessels (i.e., arterioles, capillaries, and venules) compared to in veins and feed arteries \[[@B16], [@B17]\]. We have previously combined MD and NIRS to study the effects of RW of different duration \[[@B9]\] and RW with superimposed mental load \[[@B10]\] on % StO~2~ in the pain-free trapezius muscle. We found small changes in % StO2 and intramuscular lactate, indicative of a normal response to increased physical demands \[[@B9]\]. In one recent study no statistically significant differences for oxygenated haemoglobin during RW were reported between TM and healthy controls \[[@B18]\].

The aims of this study, which was purposely designed as a comparison to our previous study on asymptomatic females \[[@B9]\], were to investigate whether an interstitial accumulation of sensitising substances (glutamate, PGE~2~), or local metabolic changes indicative of an insufficient oxygen supply (e.g., greatly increased \[lactate\] and decreased % StO~2~) is evident during RW in subjects with TM (*n* = 14).We also wanted to investigate how % StO~2~, blood lactate, and intramuscular \[lactate\] relate during RW in TM.

2. Materials and Methods {#sec2}
========================

2.1. Participants {#sec2.1}
-----------------

Fourteen females with trapezius myalgia (TM) participated in the study. The group had a mean age of 40 (±8) years, height 167 (±4) cm, weight 66 (±9.5) kg, and BMI 23.0 (±2.3). The pain subjects were matched in age to a group of healthy asymptomatic females, who had participated in a previous study at our laboratory, and in which the same experimental protocol was used \[[@B9]\], to admit comparisons to be made.

Participants were required to be right-handed, nonsmokers, and not allergic to local anaesthesia. Further inclusion criteria were as follows: during the clinical examination subjects were required to (i) report pain of a duration of at least 3 months from the neck-shoulder region, (ii) verify pain in the upper part of the trapezius muscle with a pain drawing, (iii) have the most pronounced complaints on the side subjected to the greatest workload, and (iv) have reason to believe that the pain was caused by their work, that is, that they reported that the onset of their pain problems coincided with performance of static and/or repetitive work tasks. Also, that they reported less pain when being off work, and/or increased pain when coming back to work after a holiday.

All participants were examined by the same physiotherapist. Exclusion criteria were (a) previous trauma to the neck or shoulder, (b) signs of shoulder tendonitis or shoulder joint affection, (c) signs of nerve affection, (d) pronounced pain from more than three body regions, and (e) neurological or metabolic diseases, or (f) other diseases that demanded continuous medication.

The Nordic Ministry Council Questionnaire (NMCQ) \[[@B19]\] and the visual analogue scale (VAS) were used to survey pain during the last 12 months and at the time of participation. All participants reported pain from the neck-shoulder area during the last 7 days. The median (range) for the VAS-ratings of perceived pain in the right shoulder were 47 (12--79) for the last 12 months, 34 (14--63) for the last 7 days, and 27 (4--78) when arriving at the laboratory. The mean (±SD) duration of complaints from the neck-shoulder was 70.5 (±74.7) months. None of the subjects were on sick-leave at the time of the study.

The participants were recruited through contacts with local industries and through advertisement on the university hospital\'s intranet. The participants either worked at an assembly line (in a car factory) or at a VDU-station, thus performing work tasks of a repetitive and static character. All participants gave their informed and signed consent prior to inclusion in the study. The study conformed to the ethical standards laid down in the 1964 Declaration of Helsinki and was approved by the Ethical Committee of the Medical Faculty of the University of Umeå (*Dnr 2004:M-150*).

2.2. Methods {#sec2.2}
------------

### 2.2.1. Experimental Protocol {#sec2.2.1}

The experimental design is shown in [Figure 1](#fig1){ref-type="fig"}. The experimental conditions were exactly the same as in the previous study on asymptomatic control subjects \[[@B9]\] (same experimental protocol, same laboratory room and equipment, same controlled room temperature, all probe insertions were performed by the same medical doctor, and all analyses were performed by the same laboratory technicians). In addition to the previous protocol, the participants perceived pain intensity were also assessed. All experiments started at 7 a.m. The subjects were instructed not to perform any kind of heavy physical exercise 48 hours prior to the experiment, and to arrive fasting to the laboratory where they were given a standardised breakfast. They were also asked to refrain from using pain medication (NSAIDs) three days before the experiment to avoid interference with the pain substances under study, but also due to the increased risk of bleeding during the procedure (paracetamol was allowed). In the preparation period, before the MD-probe was inserted and the optical probe for oxygen saturation measurements was attached to the skin, measurements of skin-fat layer (SFL) and trapezius muscle thickness over the approximate site of the O~2~-probe were performed using ultrasonography \[[@B9], [@B10]\]. Subjects then rested comfortably seated for a total of 120 minutes (90 minutes stabilisation + 30 minutes baseline) before the 30 minutes work-period began.

The repetitive low-load work, also used by Flodgren et al. \[[@B9], [@B10]\], was designed to simulate an occupational work task. It consisted in alternatively pushing in a piston and pressing down a button with the use of a hand-held manipulandum (130 grams), while seated at a table. The subjects maintained a pace of 30 work cycles per minute, with the aid of a metronome; a single piston push followed by a button press constituting one work cycle. The workstation was adjusted to each subject to provide optimal ergonomic conditions ([Figure 2](#fig2){ref-type="fig"}). In a pilot study (unpublished data) we used electromyography to assess the trapezius muscle activity during the same type of work. We then found the mean electrical activity to be 9.3% of maximal voluntary contraction, which is similar to muscle activity measured during low-load RW at a real work place \[[@B20]\].

After the performance of the repetitive work subjects rested, comfortably seated, for yet another 60 minutes (see [Figure 1](#fig1){ref-type="fig"}). All subjects completed the work task. Throughout the experiment local % StO2 was recorded, microdialysate samples and capillary blood for lactate analyses were obtained, subjectively perceived exertion (Borg CR-10) and perceived pain intensity (VAS) were assessed, as shown in [Figure 1](#fig1){ref-type="fig"}. The room temperature was between 22 and 24 degrees Celsius during experiments.

### 2.2.2. Microdialysis {#sec2.2.2}

After local anaesthesia of the skin and subcutaneous tissue by injection of 1.5 mL Xylocain (10 mg ml^−1^), a microdialysis probe (CMA 60, CMA/Microdialysis AB, Sweden, 20 kDa molecular cut-off, membrane length 30 mm, 0.5 mm outer diameter) was implanted in the middle third of the upper part of the trapezius muscle in the direction lateral to medial. The same investigator performed all probe insertions, and ultrasonography was used to confirm the placement of the probe (Aloka SSD-2000, Aloka Co., Ltd., Japan). The catheter was secured to the skin with adhesives, connected to a portable syringe pump (CMA 107, CMA/Microdialysis, AB, Sweden), and perfused with solution containing 147 mM L^−1^Na^+^, 4 mM L^−1^K^+^, 2.3 mM L^−1^Ca^2+^, and 156 mM L^−1^ Cl^−^ (perfusion fluid T1, CMA/Microdialysis AB, Stockholm, Sweden), at a flow rate of 2 *μ*L min^−1^. The pump was secured in level with the probe. After insertion of the probe in the muscle, the subjects rested for 90 minutes to allow the tissue to stabilise after the initial trauma of probe insertion \[[@B11], [@B12], [@B21]\]. Samples were obtained every 30th minute during the initial two hours of rest, and every 15th minute during work and recovery. The last sample obtained during rest will be referred to as baseline. All probes kept functioning throughout the experiment. The samples were immediately frozen to −70° until analyses were performed. All samples were coded by the authors and analysed blindly by an independent laboratory technician. Lactate, glutamate and pyruvate were analysed with the CMA 600 Microdialysis Analyser (CMA Microdialysis, Solna, Sweden), and PGE~2~ with a radioimmunoassay kit (NEN, Du Pont, Boston, Mass, USA). The detection limits are 0.1 mmol × L^−1^ for lactate, 10 *μ*mol × L^−1^ for pyruvate and 1 *μ*mol × L^−1^ for glutamate. The detection limit for the PGE~2~ assay is 0.5 pg mL^−1^.

### 2.2.3. Oxygen Saturation (% StO~2~) {#sec2.2.3}

Measurements of trapezius muscle % StO~2~ were performed during the experiment using a near infrared spectrometer, NIRS (INSPECTRA Tissue Spectrometer---model 325, Hutchinson Technology Inc, Netherlands).

A self-adhesive O~2~-shield was placed on the skin overlying the upper part of the trapezius muscle, medial of the MD-probe insertion site. Before connecting the optical cable to the shield, the system was calibrated according to instructions from the manufacturers, that is, inserted in a light scattering calibrator for capturing reference light intensities of all wavelengths. All tissue measurements were related to the reference measurement, thereby converting light intensity measurements to optical absorbance. Optical absorbance values were further processed into a scaled second derivative absorbance spectrum, whereby a measure of percent oxygen saturation was obtained. The software supplied with the In Spectra device allows for absolute values of % StO~2~. The distance between the light transmitter and the detector was 12 mm, and the sampling frequency 0.3 Hz.

### 2.2.4. Blood Sampling {#sec2.2.4}

In order to assess possible systemic effects in response to work, that is, changes in blood lactate concentration, capillary blood samples were obtained from a right hand finger at baseline, directly after work and after the recovery period ([Figure 1](#fig1){ref-type="fig"}). The coded samples were immediately put on ice, and were later the same day analysed with a lactate analysis device YSI 2300 STAT plus (Clandon Scientific, Famborough, UK) by an independent laboratory technician.

### 2.2.5. Rating of Perceived Exertion (RPE) and Perceived Pain Intensity (RPP) {#sec2.2.5}

At baseline, and at the end of both the work and the recovery period (see [Figure 1](#fig1){ref-type="fig"}), subjects were required to rate their (i) perceived exertion of the right shoulder in accordance to the Borg CR-10 scale \[[@B22]\], with 0 = no fatigue and 10 = severe fatigue, and (ii) their perceived pain intensity in the right shoulder, using the nonhatched VAS, marked at one end as "no pain at all" and at the other "worst pain imaginable" \[[@B23]\].

### 2.2.6. Estimation of Skin-Fat Layer and Trapezius Muscle Thickness {#sec2.2.6}

Measurements of skin-fat layer (SFL) and trapezius muscle thickness were performed using ultrasonography, with a 75 mm probe (Aloka SSD-2000, Aloka Co., Ltd., Japan). Measurements were performed at three measuring-points over the upper trapezius muscle medially of the MD-probe insertion point. (1, 3.75 and 7.5 cm)

### 2.2.7. Data Analyses and Statistics {#sec2.2.7}

SPSS statistical software, version 13.0 (Chicago, III, USA) was used for all analyses. The level of significance was set to *P* \< .05. The Kolmogorov-Smirnov test was used to test for normal distribution, and data for all variables was normally distributed.

The change in substance concentration relative to work was calculated as the baseline values subtracted from the values obtained after work (work-baseline = change).

Pearson test was used to investigate possible correlations between (i) pain substances (glutamate and PGE~2~) and pain intensity, (ii) IMMD lactate and local muscle oxygenation, (iii) local (IMMD lactate) and systemic (blood lactate) changes, and (iv) key metabolites (IMMD lactate and glutamate).

Repeated measures ANOVA (RM ANOVA) were used for the within group comparisons of data for the different variables in response to work and recovery (except for the RPE- and RPP-data). If the assumption of sphericity of variance was violated in the RM ANOVA, the Huyn-Feldt correction was used. The sequential Bonferroni \[[@B24]\] was used to compare specific pairs of means when the RM ANOVA revealed a significant difference.

To relate the oxygenation and the MD-data in time, a mean value of the oxygenation data recorded during a 5-min period just before each sampling of dialysate was calculated. Data are presented as means ± SD in both text and graphs, except for the RPE and RPP which are presented as median and range. Wilcoxon nonparametric test was used for the within group comparisons of the subjective ratings.

3. Results {#sec3}
==========

3.1. Biochemical Alterations during Work {#sec3.1}
----------------------------------------

During work \[glutamate\] increased (54%) (*P* \< .0001, *F* = 16.957), and decreased to 26% below baseline during the recovery period (*P* \< .0001, *F* = 14.293) (see [Figure 3(a)](#fig3){ref-type="fig"}).

The mean IMMD \[PGE~2~\] remained unchanged during work (*P* = .300), but showed a significant overall decrease (40% lower than baseline) during recovery (*P* = .004, *F* = 5.224) (see [Figure 3(b)](#fig3){ref-type="fig"}).

An overall significant increase (28%) in mean IMMD \[lactate\] was found in response to work (*P* = .003, *F* = 10.813), and recovery (*P* \> .001, *F* = 7.392) as compared to baseline (see [Figure 3(c)](#fig3){ref-type="fig"}).

Also, \[pyruvate\] increased significantly during work (*P* \< .0001, *F* = 36.4), and continued to increase progressively (up to 60% \> baseline) during the recovery period (*P* \< .0001, *F* = 25.3) (see [Figure 3(d)](#fig3){ref-type="fig"}).

3.2. Oxygen Saturation (% StO~2~) {#sec3.2}
---------------------------------

A small, but significant, decrease in % StO~2~ in response to work was found (*P* = .016, *F* = 7.816), and directly after the cessation of work baseline was re-established (see [Figure 4](#fig4){ref-type="fig"}).

3.3. Blood Lactate {#sec3.3}
------------------

Plasma \[lactate\] decreased significantly in response to work (*P* = .005; *F* = 8.109), from 1.1  mmol × L^−1^ (SD ± 0.3) at baseline to 0.9  mmol × L^−1^ (SD ± 0.2) after work and baseline was re-established at the end of the recovery period (1.3 ± 0.6).

3.4. Rating of Perceived Exertion (RPE) and Pain Intensity (RPP) {#sec3.4}
----------------------------------------------------------------

The median (range) RPE in the right shoulder (Borg CR-10), increased significantly from 1.5 (0--3.5) at baseline to 7.0 (3.0--7.0) after work, and remained increased also after recovery 2.25 (0--4.5) The median (range) RPP in the right shoulder (VAS) increased (*P* \< .001) from 17.5 (2--52) at baseline, to 69 (28--82) after work and tended to be significantly increased also at the end of recovery 26.5 (3--69) (*P* = .054).

3.5. Skin-Fat Layer and Trapezius Muscle Thickness {#sec3.5}
--------------------------------------------------

The mean SFL (fascia included) and the mean trapezius muscle thickness for the three measuring-points medial to the MD-probe insertion point (1, 3.5 and 7 cm) were 4.6 ± 0.5, 4.7 ± 0.3 and 4.5 ± 0.3 mm and 12.3 ± 0.4 mm, and 12.2 ± 0.5 and 10.0 ± 0.6 mm, respectively. Mean values for the SFL (4.6 ± 0.4 mm) and the trapezius muscle thickness (11.5 ± 0.5 mm) were calculated.

3.6. Correlations {#sec3.6}
-----------------

A significant negative correlation was found between changes in IMMD \[lactate\] and plasma \[lactate\] during work (*P* \< .05), and a tendency to a correlation between IMMD lactate and % StO~2~ (*P* = .073). The pain intensity was uncorrelated to IMMD \[glutamate\] (*P* = .276) and \[PGE~2~\]. (*P* = .492), but significantly correlated to the perceived exertion in the shoulder (*P* \< .0001). A significant correlation was also found between changes in IMMD \[glutamate\] and IMMD \[lactate\] during work (*P* \< .05).

4. Discussion {#sec4}
=============

The main results of the present study were: significantly increased IMMD \[glutamate\] and \[lactate\], unchanged \[PGE~2~\], and decreased % StO~2~ in the trapezius muscle during work in females with TM. Furthermore, that glutamate and PGE~2~ were uncorrelated to pain intensity.

4.1. Glutamate and PGE~2~ {#sec4.1}
-------------------------

Glutamate is a well-known pain-mediator in the CNS \[[@B25], [@B26]\], and suggested to contribute to localised pain and peripheral sensitisation in certain pain conditions \[[@B13], [@B27], [@B28]\]. It is also a key metabolite in cellular metabolism \[[@B29]\]. In our study we found a significant increase in IMMD \[glutamate\] in response to work (54%), which was in accordance with our previous results for healthy controls \[[@B9]\]. However, at all time points \[glutamate\] was lower in TM, and uncorrelated to pain intensity \[[@B9]\]. While we found a moderate increase in \[glutamate\], the suggested concentration needed to excite and sensitize nociceptors is 2-3-fold greater than physiological concentrations \[[@B30]\]. These findings taken together do not support an involvement of glutamate in peripheral pain conditions. They are best interpreted as signs of normally increased metabolism in response to work.

The increase in \[glutamate\] in TM in response to work was also in accordance with results reported by others \[[@B13]\]. In contrast, Rosendal et al. found overall higher \[glutamate\] in TM, and a correlation between pain ratings and \[glutamate\] \[[@B13]\]. A recent study reported higher \[glutamate\] in TM, but no definite baseline was used as comparison \[[@B14]\]. It should be noted that the increased \[glutamate\] reported \[[@B13], [@B14]\] was similar to absolute resting concentrations reported in the trapezius of pain subjects and controls \[[@B12]\].

PGE~2~ is known to act directly on nociceptors, and for its ability to sensitise nociceptors to other substances \[[@B31]\]. PGE~2~ is also an important regulator of blood flow \[[@B16], [@B32]\], but its effect is highly dependent on intensity and mode of exercise, that is, during high intensity dynamic contractions, \[PGE~2~\] is reported to increase significantly, but to remain unchanged during low intensity static contractions \[[@B33]\].

In our study IMMD \[PGE~2~\] did not increase in response to work, which is in agreement with our previous results on healthy subjects \[[@B9]\]. Furthermore, \[PGE~2~\] was uncorrelated to pain intensity. These findings suggest that there is no ongoing inflammation in the chronic phase of TM. Our findings and conclusions are in general agreement with the results for \[PGE~2~\] reported by Ashina et al. \[[@B15]\].

However, tissue damage and inflammation may still be initiating factors for the development of muscle pain \[[@B34]\], and a shift from pain mechanisms in the periphery to the CNS may occur at a later stage in the disease process \[[@B35]\].

4.2. Lactate, Pyruvate, and % StO~2~ {#sec4.2}
------------------------------------

Lactate is an important fuel source and a glukoneogenetic precursor \[[@B36], [@B37]\]. Muscles produce lactate to yield energy during anaerobic conditions, but there is also a significant lactate production in the fully oxygenated contracting muscle \[[@B38]\]. In our study, we found significantly increased \[lactate\] in response to work TM, which was in accordance with our previous results for healthy females \[[@B9]\]. Ashina et al. \[[@B39]\] also found similar \[lactate\] in pain subjects and controls in response to static work. However, higher \[lactate\] in TM in response to RW has been reported \[[@B13], [@B18]\], findings which the same authors were unable to verify in an occupational study \[[@B14]\]. However, many of the subjects in \[[@B13]\] were on sick-leave, while in the latter participants were occupationally active \[[@B18]\].

During prolonged low-intensity work oxidation of lactate into pyruvate is enhanced, and muscles revert from net lactate release to net uptake \[[@B40]\]. We found a significant increase in \[pyruvate\] during work, and a progressive increase during recovery, which differed from our results on healthy controls \[[@B9]\]. Larsson et al., reported unchanged \[pyruvate\] during work in both myalgic and healthy workers, but this study had no real baseline for comparison \[[@B14]\]. It may be speculated that the higher \[pyruvate\] may be due to a greater activation of fatigable type II fibres in subjects with TM, in comparison to asymptomatic subjects, which would be in accordance with muscle activation patterns reported for chronic pain cases \[[@B41]\].

As far as we know, we are first to combine MD and NIRS to investigate biochemical alterations in the trapezius muscle in response to RW \[[@B9], [@B10]\]. In the present study, we found a significant decrease in local muscle % StO~2~ during work, and a tendency to a significant correlation between % StO~2~ and IMMD \[lactate\]. Our findings are in general agreement with the results reported by Sjøgaard et al. \[[@B18]\]. The decrease in % StO~2~ and the increase in IMMD \[lactate\] did not differ from our previous results on healthy controls, that is why these findings must be interpreted as a normal response to increased metabolic demands.

Blood \[lactate\] decreased during work and was negatively correlated with IMMD \[lactate\], which may be explained by an enhanced uptake and use of lactate as a fuel by active muscles during prolonged low-load work \[[@B40]\]. During high-intensity work, \[lactate\] in muscle and blood is correlated \[[@B42], [@B43]\],while low-intensity work is suggested not to cause systemic effects \[[@B16], [@B44]\].

4.3. Methodological Considerations {#sec4.3}
----------------------------------

### 4.3.1. Microdialysis {#sec4.3.1}

After the trauma of probe insertion, interstitial substance concentrations are abnormal and the influx of substances random. To avoid biased results sufficient time for the establishment of a new steady-state must be allowed \[[@B11]\]. We applied a 90 minutes stabilisation time, which is ample time for stabilisation of lactate, pyruvate \[[@B21]\], glutamate \[[@B12]\], but maybe not for PGE~2~, which decreased below baseline during recovery.

Refraining from calibrating the probe in vivo is suggested to introduce bias since the relative recovery of substances (RR) is reported to increase with high intensity exercise in the absence of true interstitial changes \[[@B11], [@B44]\]. However, most studies of low-load work have reported no change \[[@B13], [@B14], [@B39], [@B45]\] or a small change \[[@B13]\] in RR of lactate in the trapezius muscle during work. This lack of change in RR may be explained by that intramuscular pressure does not increase in the trapezius during low-load work \[[@B46]\], and that the changes in blood flow are small \[[@B39]\],which are suggested not to affect RR of substances in vivo \[[@B47], [@B48]\]. We did not assess RR, and cannot therefore exclude the presence of a bias, although we find it unlikely that this bias is significant.

### 4.3.2. Near-Infrared Spectroscopy (NIRS) {#sec4.3.2}

Ideally, we also should have measured blood-flow (BF), since metabolic insufficiencies may be the result of impaired BF \[[@B49]\]. Existing results are conflicting and provide no convincing evidence for impaired BF in TM as compared to healthy controls \[[@B14], [@B18], [@B39], [@B45]\].

NIRS may provide information about a possible mismatch between metabolic requirements and blood flow locally in muscle \[[@B16]\] and is considered a valid \[[@B50]\], and reliable tool \[[@B51]\] for measuring local muscle oxygenation during work.

Heterogeneity of blood flow and oxygen consumption distributions within a muscle \[[@B43], [@B52], [@B53]\], work intensity and level of training \[[@B16]\] and mode of exercise \[[@B54]\] may influence NIRS-measurements. In this, and in previous studies \[[@B9], [@B10]\], the work and the position of the probe were standardised, to enable appropriate comparison between studies \[[@B55]\].

The probe was chosen to ensure that data was obtained from the trapezius, and not from underlying muscle. It may be argued that the measuring depth of the probe may not have been sufficient to accurately assess changes in %StO~2~. However, the muscle volume measured with NIRS is controversial, and while the signal is presumed to be obtained mostly from a tissue depth of approximately 60% of the transmitter-detector distance, a banana-shaped region of sensitivity extends both above and below this depth \[[@B17]\]. Since the skin overlying muscle in lean subjects contributes \<5% of the signal \[[@B16]\], our measurement should mainly originate from muscle.

The discrepancies between the few studies that have studied the effect of low-load work on metabolism and sensitising substances, both in methodology, and subjects studied, emphasise that more independent studies are needed.

5. Conclusions {#sec5}
==============

The changes in substance concentrations and oxygenation found in this study indicate normal increase in metabolism in response to work but no ongoing inflammation in subjects with TM. Our results do not support the role of glutamate as a pain mediator in the periphery.
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![Experimental design. Schematic of the experimental design with 90 minutes stabilisation period, 30 minutes baseline, 30 minutes work, and a 60 minutes recovery period. Arrows indicate time points for sampling of dialysate, assessment of perceived exertion with the Borg CR-scale (RPE), assessment of perceived pain intensity with VAS (RPP), and capillary blood sampling (BS).](JBB2010-513803.001){#fig1}

![Repetitive work model. The low-load repetitive work consisted of (a) pushing in a piston and (b) pressing down a button on the table with a handheld manipulandum, at a pace of 30 work cycles per minute.](JBB2010-513803.002){#fig2}

![(a) IMMD glutamate concentrations. Mean (±SD) intramuscular microdialysate \[glutamate\] (*μ*M L^−1^) at baseline, in response to work and recovery. Percent difference in comparison to baseline is depicted on the right hand *y*-axis. Significant differences with respect to baseline concentrations are indicated with \* for a *P*-value \<.05 and \*\* for a *P*-value \<.001. (b) IMMD PGE~2~ concentrations. Mean (±SD) intramuscular microdialysate \[PGE~2~\] (*μ*g mL^−1^) at baseline, in response to work and recovery. Percent difference in comparison to baseline is depicted on the right hand *y*-axis. Significant differences with respect to baseline concentrations are indicated with \* for a *P*-value \<.05 and \*\* for a *P*-value \<.001. (c) IMMD lactate concentrations. Mean (±SD) intramuscular microdialysate \[lactate\] (mM L^−1^) at baseline, in response to work and recovery. Percent difference in comparison to baseline is depicted on the right hand *y*-axis. Significant differences with respect to baseline concentrations are indicated with \* for a *P*-value \<.05 and \*\* for a *P*-value \<.001. (d) IMMD pyruvate concentrations. Mean (±SD) interstitial microdialysate \[pyruvate\] (mM L^−1^) at baseline, during work and recovery. Percent difference in comparison to baseline is depicted on the right hand *y*-axis. Significant differences with respect to baseline concentrations are indicated with \* for a *P*-value \<.05 and \*\* for a *P*-value \<.001.](JBB2010-513803.003){#fig3}

![Muscle oxygen saturation. Mean (±SD) local trapezius muscle oxygen saturation (% StO~2~) at baseline, during work and recovery. Significant differences with respect to baseline concentrations are indicated with \* for a *P*-value \<.05.](JBB2010-513803.004){#fig4}
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